Jim Simons Purple Biotech Ltd. Call Options Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PPBT
# of Institutions
23Shares Held
2.64MCall Options Held
6.6KPut Options Held
0-
Armistice Capital, LLC New York, NY2.12MShares$867,1500.02% of portfolio
-
Kingswood Wealth Advisors, LLC San Diego, CA186KShares$76,3010.01% of portfolio
-
Morgan Stanley New York, NY137KShares$56,0100.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il58KShares$23,7890.0% of portfolio
-
Xtx Topco LTD London, X029.1KShares$11,9300.0% of portfolio
About PURPLE BIOTECH LTD.
- Ticker PPBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,303,300
- Market Cap $7.5M
- Description
- Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug for cancer patients in the United States. Its oncology pipeline includes CM24, a monoclonal antibody that blocks carcinoembryonic antigen related cell adhesion molecule 1 as a combination therapy with anti-PD-1 checkpoint inhi...